| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate |
2005-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a04912de070369a2f0910a1169a63ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acf94265deee6f27c4258587d91c5869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e5cefe7c782ab301c564297f162e805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63441779de1e0a5fa952d9f3a54c938f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec6175c2d33790a4b6a6a5f2868618dc |
| publicationDate |
2007-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0507839-A |
| titleOfInvention |
tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline |
| abstract |
TETRAHYDROISOQUINOLINYL QUINAZOLINE AND ISOQUINOLINE DERIVATIVES. The present invention relates to substituted quinazoline and isoquinoline compounds which lend themselves as effective phosphodiestrease (PDE) inhibitors. In particular, the invention relates to compounds that are selective PDE-10 inhibitors. The invention further relates to intermediates for the preparation of said compounds; pharmaceutical compositions comprising said compounds and the use of said compounds a method for treating some central nervous system (CNS) disorders or other disorders. |
| priorityDate |
2004-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |